Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-024713

Director sold 7,500 shares at an average $184.53 ($1,383,969)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-01 Sale : show line 1 in the form −241 $180.27 $43,446 443,250 D
2021-04-01 Sale : show line 2 in the form −200 $181.83 $36,365 443,050 D
2021-04-01 Sale : show line 3 in the form −700 $183.19 $128,233 442,350 D
2021-04-01 Sale : show line 4 in the form −2,272 $184.22 $418,539 440,078 D
2021-04-01 Sale : show line 5 in the form −3,487 $185.21 $645,844 436,591 D
2021-04-01 Sale : show line 6 in the form −600 $185.90 $111,542 435,991 D
Open-market sales · 7,500 sh · avg $184.53 · $1,383,969
Loading xslF345X03/doc4.xml…